DK528982A - Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner - Google Patents

Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner Download PDF

Info

Publication number
DK528982A
DK528982A DK528982A DK528982A DK528982A DK 528982 A DK528982 A DK 528982A DK 528982 A DK528982 A DK 528982A DK 528982 A DK528982 A DK 528982A DK 528982 A DK528982 A DK 528982A
Authority
DK
Denmark
Prior art keywords
prostaglandines
didehydro
procedure
preparation
Prior art date
Application number
DK528982A
Other languages
Danish (da)
English (en)
Inventor
Franco Faustini
Vittoria Villa
Carmelo Gandolfi
Enrico Di Salle
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of DK528982A publication Critical patent/DK528982A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK528982A 1981-11-27 1982-11-26 Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner DK528982A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8135799 1981-11-27

Publications (1)

Publication Number Publication Date
DK528982A true DK528982A (da) 1983-05-28

Family

ID=10526190

Family Applications (1)

Application Number Title Priority Date Filing Date
DK528982A DK528982A (da) 1981-11-27 1982-11-26 Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner

Country Status (19)

Country Link
US (1) US4543353A (pt)
JP (1) JPS58103356A (pt)
AT (1) AT392964B (pt)
AU (1) AU552847B2 (pt)
BE (1) BE895137A (pt)
CA (1) CA1237718A (pt)
CH (1) CH656877A5 (pt)
DE (1) DE3241399A1 (pt)
DK (1) DK528982A (pt)
FI (1) FI77442C (pt)
FR (1) FR2517302A1 (pt)
GB (1) GB2111986B (pt)
IE (1) IE54347B1 (pt)
IL (1) IL67103A (pt)
IT (1) IT1153080B (pt)
NL (1) NL8204611A (pt)
SE (1) SE454588B (pt)
SU (2) SU1301309A3 (pt)
ZA (1) ZA827825B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2130575B (en) * 1982-11-09 1985-12-11 Erba Farmitalia Amide derivatives of 13, 14-didehydro-cycloalkyl-prostaglandins
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
US4877871A (en) * 1988-06-14 1989-10-31 Nabisco Brands, Inc. Synthesis of sucrose polyester
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
ATE281432T1 (de) 1999-03-05 2004-11-15 Univ Duke C-16 ungesätigte fp-selektive prostaglandin analoge
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) * 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
AU2006349143B2 (en) * 2006-10-02 2013-07-18 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
US7507817B2 (en) * 2006-11-17 2009-03-24 Allergan, Inc. Prostaglandin prodrugs
JP2010529101A (ja) 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
US7964595B2 (en) * 2008-01-18 2011-06-21 Allergan, Inc. Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension
EP2285796A1 (en) * 2008-05-09 2011-02-23 Allergan, Inc. Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
JP2011520807A (ja) * 2008-05-09 2011-07-21 アラーガン インコーポレイテッド 治療用置換ヒダントイン類および関連化合物
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
CN111808011B (zh) 2008-12-04 2024-02-27 泰飞尔生物医药(苏州)有限公司 高穿透性组合物及其应用
KR20180021919A (ko) 2009-11-09 2018-03-05 알러간, 인코포레이티드 모발 성장을 촉진하기 위한 조성물 및 방법
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
JP5925158B2 (ja) * 2013-06-04 2016-05-25 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
JP6030168B2 (ja) * 2015-03-09 2016-11-24 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
JP6306067B2 (ja) * 2016-01-08 2018-04-04 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE445717C (de) * 1924-05-16 1927-06-17 Chr Jonathan Sternkopf Vorrichtung zum Herstellen von Holzschliff fuer die Papier- u. dgl. Fabrikation
GB1425961A (en) * 1972-04-13 1976-02-25 Erba Carlo Spa Prostanoic acid derivatives
IT1053781B (it) * 1974-09-25 1981-10-10 Erba C S P A Ora Farmitalia Omega nor cicloalcil 13.14 deidro prostaglandine
IL51877A (en) * 1976-06-01 1981-09-13 Carlo Erba Sa -nor-16-benzyl or phenoxy-13,14-dehydro-prostaglandins and process for their preparation
FI71138C (fi) * 1976-12-31 1986-11-24 Erba Farmitalia Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner
IT1088966B (it) * 1977-11-15 1985-06-10 Erba Carlo Spa 13,14-dideidro-prostaglandine
SE446993B (sv) * 1980-07-09 1986-10-20 Mo Och Domsjoe Ab Forfarande for framstellning av blekt slipmassa
SE434069B (sv) * 1980-07-09 1984-07-02 Mo Och Domsjoe Ab Forfarande for framstellning av slipmassa

Also Published As

Publication number Publication date
IT8224327A0 (it) 1982-11-19
US4543353A (en) 1985-09-24
SE8206731D0 (sv) 1982-11-25
SE8206731L (sv) 1983-05-28
JPS58103356A (ja) 1983-06-20
DE3241399C2 (pt) 1990-10-31
GB2111986A (en) 1983-07-13
AU552847B2 (en) 1986-06-26
IT1153080B (it) 1987-01-14
CH656877A5 (de) 1986-07-31
GB2111986B (en) 1985-05-15
BE895137A (fr) 1983-05-25
CA1237718A (en) 1988-06-07
AU8979782A (en) 1983-06-02
IT8224327A1 (it) 1984-05-19
FI77442B (fi) 1988-11-30
IE822568L (en) 1983-05-27
FR2517302B1 (pt) 1984-12-14
ATA421482A (de) 1990-12-15
DE3241399A1 (de) 1983-06-01
FI77442C (fi) 1989-03-10
SE454588B (sv) 1988-05-16
IL67103A0 (en) 1983-02-23
AT392964B (de) 1991-07-25
FI824017L (fi) 1983-05-28
FR2517302A1 (fr) 1983-06-03
SU1321372A3 (ru) 1987-06-30
IL67103A (en) 1986-11-30
ZA827825B (en) 1983-08-31
FI824017A0 (fi) 1982-11-23
SU1301309A3 (ru) 1987-03-30
NL8204611A (nl) 1983-06-16
IE54347B1 (en) 1989-08-30
JPH0369899B2 (pt) 1991-11-05

Similar Documents

Publication Publication Date Title
DK528982A (da) Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner
DK219382A (da) Fremgangsmaade til fremstilling af 1,2-diaminocyclobuten-3,4-dioner
DK260682A (da) Fremgangsmaade til fremstilling af partikelformige geler
DK65882A (da) Fremgangsmaade til fremstilling af substituerede phosphonamider
DK112582A (da) Fremgangsmaade til fremstilling af triazolonderivater
DK149949C (da) Analogifremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
DK408580A (da) Fremgangsmaade til fremstilling af 1,8-naphthydridinforbindelser
DK66582A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK161147C (da) Analogifremgangsmaade til fremstilling af oe3haa-imidazo-oe5,1-daa-1,2,3,5-tetrazin-4-onderivater
DK491582A (da) Fremgangsmaade til fremstilling af morphinanderivater
DK352082A (da) Fremgangsmaade til fremstilling af ergopeptinderivater
DK161482A (da) Fremgangsmaade til fremstilling af et analgetisk praeparat
DK153282A (da) Fremgangsmaade til fremstilling af bismethinisoindoliner
DK127482A (da) Fremgangsmaade til fremstilling af dipeptidforbindelser
DK239382A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK117779A (da) Fremgangsmaade til fremstilling af 2,6-dialkoxybenzamider
DK150986C (da) Fremgangsmaade til fremstilling af azopigmentpraeparater
DK305982A (da) Fremgangsmaade til fremstilling af amidobenzamider
DK160555C (da) Fremgangsmaade til fremstilling af eburnamoninderivater
DK107482A (da) Fremstilling af 2,3-dichlor-5-trichlormethylpyridin
DK116982A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK113483D0 (da) Fremgangsmade til fremstilling af 3,4-diphenyl-5-methylpyrazolderivater
DK507282A (da) Fremgangsmaade til fremstilling af azinorifamycin forbindelser
DK375882A (da) Fremgangsmaade til fremstilling af benzisoxazolderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment